Eden Research plc
EDNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 34.8% | 74.7% | 48.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 43.5% | 55.3% | 11.3% | 2.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -36.9% | -195.6% | -101.7% | -221% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -44.3% | -203.5% | -122.4% | -227% |
| EPS Diluted | -0.004 | -0.015 | -0.006 | -0.007 |
| % Growth | 76.6% | -161% | 19.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |